Phase II study of Carboplatin and alternate-day administrations of TS-1 in patients with advanced squamous cell lung cancer.
Phase of Trial: Phase II
Latest Information Update: 15 Nov 2017
At a glance
- Drugs Carboplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Lung cancer
- Focus Therapeutic Use
- 05 Mar 2013 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 22 Jan 2013 New trial record